How this dad came to lead a Seattle biotech after son’s rare diagnosis

Pharmaceutical industry veteran Matthew Lumley reached out to Myosana Therapeutics after his son was diagnosed with a devastating disease. Now he’s the company’s CEO.
Click here to view original post